Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Platelet Aggregation Inhibitors | 1 | 2016 | 47 | 0.500 |
Why?
|
| Coronary Artery Disease | 2 | 2016 | 132 | 0.460 |
Why?
|
| Stents | 5 | 2004 | 81 | 0.340 |
Why?
|
| Strontium Radioisotopes | 4 | 2003 | 8 | 0.270 |
Why?
|
| Beta Particles | 3 | 2003 | 7 | 0.250 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2002 | 19 | 0.240 |
Why?
|
| Myocardial Infarction | 3 | 2016 | 132 | 0.170 |
Why?
|
| Coronary Restenosis | 3 | 2004 | 10 | 0.160 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 168 | 0.120 |
Why?
|
| Hemorrhage | 1 | 2016 | 82 | 0.120 |
Why?
|
| Risk | 1 | 2016 | 203 | 0.120 |
Why?
|
| Angioplasty, Balloon, Coronary | 3 | 2004 | 40 | 0.120 |
Why?
|
| Brachytherapy | 3 | 2004 | 46 | 0.110 |
Why?
|
| Coronary Stenosis | 2 | 2004 | 16 | 0.110 |
Why?
|
| Stroke | 1 | 2016 | 269 | 0.100 |
Why?
|
| Coronary Angiography | 3 | 2004 | 73 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2004 | 1782 | 0.070 |
Why?
|
| Myocardial Revascularization | 2 | 2004 | 16 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2004 | 1798 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2003 | 20 | 0.060 |
Why?
|
| Humans | 8 | 2016 | 26976 | 0.060 |
Why?
|
| Myocardial Stunning | 1 | 2004 | 2 | 0.060 |
Why?
|
| Laser Therapy | 1 | 2004 | 11 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2004 | 33 | 0.060 |
Why?
|
| Calcinosis | 1 | 2004 | 44 | 0.050 |
Why?
|
| Lymphokines | 1 | 2003 | 10 | 0.050 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 11 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 29 | 0.050 |
Why?
|
| DNA | 1 | 2003 | 102 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 55 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 44 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2003 | 84 | 0.050 |
Why?
|
| Visual Perception | 1 | 2002 | 29 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2002 | 6 | 0.050 |
Why?
|
| Angioplasty, Balloon | 1 | 2002 | 14 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2004 | 3526 | 0.050 |
Why?
|
| Random Allocation | 1 | 2002 | 122 | 0.050 |
Why?
|
| Middle Aged | 6 | 2004 | 9017 | 0.040 |
Why?
|
| Aged | 6 | 2004 | 9068 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 216 | 0.040 |
Why?
|
| Male | 5 | 2004 | 14756 | 0.030 |
Why?
|
| Female | 5 | 2004 | 15196 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2004 | 891 | 0.030 |
Why?
|
| Survival Rate | 2 | 2004 | 344 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2003 | 287 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 478 | 0.020 |
Why?
|
| Swine | 1 | 2004 | 71 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 139 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 5 | 0.010 |
Why?
|
| Echocardiography | 1 | 2004 | 74 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 101 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 15 | 0.010 |
Why?
|
| Injections | 1 | 2003 | 42 | 0.010 |
Why?
|
| Thoracotomy | 1 | 2003 | 30 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2003 | 3543 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 25 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2003 | 22 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 394 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 76 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 103 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 100 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2004 | 411 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 158 | 0.010 |
Why?
|
| Death | 1 | 2003 | 47 | 0.010 |
Why?
|
| Illinois | 1 | 2003 | 244 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 331 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 617 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 590 | 0.010 |
Why?
|
| Recurrence | 1 | 2002 | 309 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 626 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 667 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 762 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 667 | 0.010 |
Why?
|
| Reoperation | 1 | 2002 | 920 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 3602 | 0.010 |
Why?
|
| Adult | 1 | 2003 | 7877 | 0.010 |
Why?
|